Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
Main Authors: | Halvorsen, Sigrun, Atar, Dan, Yang, Hongqiu, De Caterina, Raffaele, Erol, Cetin, Garcia, David, Granger, Christopher B., Hanna, Michael, Held, Claes, Husted, Steen, Hylek, Elaine M., Jansky, Petr, Lopes, Renato D., Ruzyllo, Witold, Thomas, Laine, Wallentin, Lars |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104493/ |
Similar Items
-
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial
by: Jaspers Focks, Jeroen, et al.
Published: (2016) -
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
by: Rao, Meena P., et al.
Published: (2015) -
Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
by: Lee, Soyon, et al.
Published: (2012) -
Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
by: Wisløff, Torbjørn, et al.
Published: (2014) -
Resolution of a warfarin and dabigatran-resistant left atrial appendage thrombus with apixaban
by: Miwa, Yosuke, et al.
Published: (2016)